Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 92

    1.

    Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa.

    Cohen K, Grant A, Dandara C, McIlleron H, Pemba L, Fielding K, Charalombous S, Churchyard G, Smith P, Maartens G.

    Antivir Ther. 2009;14(5):687-95.PMID: 19704172 [PubMed - indexed for MEDLINE]Related articles

    2.

    Cerebral angioedema associated with enalapril.

    Decloedt E, Freercks R, Maartens G.

    Br J Clin Pharmacol. 2009 Aug;68(2):271-3. No abstract available. PMID: 19694749 [PubMed - in process]Related articles

    3.

    Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis.

    Wilkinson KA, Seldon R, Meintjes G, Rangaka MX, Hanekom WA, Maartens G, Wilkinson RJ.

    Am J Respir Crit Care Med. 2009 Oct 1;180(7):674-83. Epub 2009 Jul 23.PMID: 19628776 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G. F. Jooste Hospital).

    Kevany S, Meintjes G, Rebe K, Maartens G, Cleary S.

    S Afr Med J. 2009 May;99(5):320-5.PMID: 19588792 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pitfalls of administering drugs via nasogastric tubes.

    Decloedt E, Maartens G.

    S Afr Med J. 2009 Mar;99(3):148-9. Review. No abstract available. PMID: 19563086 [PubMed - indexed for MEDLINE]Related articles

    6.

    Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series.

    Pepper DJ, Marais S, Maartens G, Rebe K, Morroni C, Rangaka MX, Oni T, Wilkinson RJ, Meintjes G.

    Clin Infect Dis. 2009 Jun 1;48(11):e96-107.PMID: 19405867 [PubMed - indexed for MEDLINE]Related articles

    7.

    Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.

    Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, Cotton M, Maartens G.

    J Acquir Immune Defic Syndr. 2009 May 1;51(1):65-71.PMID: 19282780 [PubMed - indexed for MEDLINE]Related articles

    8.

    Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections.

    Gounden R, Bamford C, van Zyl-Smit R, Cohen K, Maartens G.

    BMC Infect Dis. 2009 Mar 9;9:26.PMID: 19272139 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effect of rifampicin on efavirenz pharmacokinetics in HIV-infected children with tuberculosis.

    Ren Y, Nuttall JJ, Eley BS, Meyers TM, Smith PJ, Maartens G, McIlleron HM.

    J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):439-43.PMID: 19223781 [PubMed - indexed for MEDLINE]Related articles

    10.

    Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance.

    Meintjes G, Rangaka MX, Maartens G, Rebe K, Morroni C, Pepper DJ, Wilkinson KA, Wilkinson RJ.

    Clin Infect Dis. 2009 Mar 1;48(5):667-76.PMID: 19191655 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.

    Nachega JB, Hislop M, Dowdy DW, Gallant JE, Chaisson RE, Regensberg L, Maartens G.

    AIDS. 2008 Oct 18;22(16):2117-25.PMID: 18832875 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome.

    Meintjes G, Wilkinson KA, Rangaka MX, Skolimowska K, van Veen K, Abrahams M, Seldon R, Pepper DJ, Rebe K, Mouton P, van Cutsem G, Nicol MP, Maartens G, Wilkinson RJ.

    Am J Respir Crit Care Med. 2008 Nov 15;178(10):1083-9. Epub 2008 Aug 28.PMID: 18755923 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing.

    Dowdy DW, Chaisson RE, Maartens G, Corbett EL, Dorman SE.

    Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11293-8. Epub 2008 Aug 11.PMID: 18695217 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.

    Boulle A, Van Cutsem G, Cohen K, Hilderbrand K, Mathee S, Abrahams M, Goemaere E, Coetzee D, Maartens G.

    JAMA. 2008 Aug 6;300(5):530-9.PMID: 18677025 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings.

    Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, Elliott JH, Murdoch D, Wilkinson RJ, Seyler C, John L, van der Loeff MS, Reiss P, Lynen L, Janoff EN, Gilks C, Colebunders R; International Network for the Study of HIV-associated IRIS.

    Lancet Infect Dis. 2008 Aug;8(8):516-23.PMID: 18652998 [PubMed - indexed for MEDLINE]Related articles

    16.

    HIV infection is associated with a lower incidence of constriction in presumed tuberculous pericarditis: a prospective observational study.

    Ntsekhe M, Wiysonge CS, Gumedze F, Maartens G, Commerford PJ, Volmink JA, Mayosi BM.

    PLoS One. 2008 Jun 4;3(6):e2253.PMID: 18523576 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: a cross-sectional study.

    Meintjes G, Schoeman H, Morroni C, Wilson D, Maartens G.

    BMC Infect Dis. 2008 May 25;8:72.PMID: 18501019 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.

    Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, Frank I, Maartens G, Nachega JB.

    PLoS Med. 2008 May 20;5(5):e109.PMID: 18494555 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa.

    Mayosi BM, Wiysonge CS, Ntsekhe M, Gumedze F, Volmink JA, Maartens G, Aje A, Thomas BM, Thomas KM, Awotedu AA, Thembela B, Mntla P, Maritz F, Blackett KN, Nkouonlack DC, Burch VC, Rebe K, Parrish A, Sliwa K, Vezi BZ, Alam N, Brown BG, Gould T, Visser T, Magula NP, Commerford PJ.

    S Afr Med J. 2008 Jan;98(1):36-40.PMID: 18270639 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis.

    Ren Y, Nuttall JJ, Egbers C, Eley BS, Meyers TM, Smith PJ, Maartens G, McIlleron HM.

    J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):566-9.PMID: 18197120 [PubMed - indexed for MEDLINE]Related articles

    21.

    Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis.

    Cohen K, van Cutsem G, Boulle A, McIlleron H, Goemaere E, Smith PJ, Maartens G.

    J Antimicrob Chemother. 2008 Feb;61(2):389-93. Epub 2007 Dec 19.PMID: 18096560 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.
    23.

    Course and complications of varicella zoster ophthalmicus in a high HIV seroprevalence population (Cape Town, South Africa).

    Richards JC, Maartens G, Davidse AJ.

    Eye (Lond). 2009 Feb;23(2):376-81. Epub 2007 Nov 2.PMID: 17975560 [PubMed - in process]Related articles

    24.

    Is it safe to switch between efavirenz and nevirapine in the event of toxicity?

    Mehta U, Maartens G.

    Lancet Infect Dis. 2007 Nov;7(11):733-8. Review.PMID: 17961859 [PubMed - indexed for MEDLINE]Related articles

    25.

    Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.

    Mohammed A, Myer L, Ehrlich R, Wood R, Cilliers F, Maartens G.

    Int J Tuberc Lung Dis. 2007 Oct;11(10):1114-20.PMID: 17945069 [PubMed - indexed for MEDLINE]Related articles

    26.

    Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.

    McIlleron H, Meintjes G, Burman WJ, Maartens G.

    J Infect Dis. 2007 Aug 15;196 Suppl 1:S63-75. Review.PMID: 17624828 [PubMed - indexed for MEDLINE]Related articles

    27.

    Tuberculosis.

    Maartens G, Wilkinson RJ.

    Lancet. 2007 Dec 15;370(9604):2030-43. Review.PMID: 17719083 [PubMed - indexed for MEDLINE]Related articles

    28.

    Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.

    Boulle A, Orrel C, Kaplan R, Van Cutsem G, McNally M, Hilderbrand K, Myer L, Egger M, Coetzee D, Maartens G, Wood R; International Epidemiological Databases to Evaluate Aids in Southern Africa Collaboration.

    Antivir Ther. 2007;12(5):753-60.PMID: 17713158 [PubMed - indexed for MEDLINE]Related articles

    29.

    CD4 T-cell responses to combination antiretroviral therapy.

    Maartens G, Boulle A.

    Lancet. 2007 Aug 4;370(9585):366-8. No abstract available. PMID: 17659332 [PubMed - indexed for MEDLINE]Related articles

    30.

    Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans.

    Rangaka MX, Diwakar L, Seldon R, van Cutsem G, Meintjes GA, Morroni C, Mouton P, Shey MS, Maartens G, Wilkinson KA, Wilkinson RJ.

    Clin Infect Dis. 2007 Jun 15;44(12):1639-46. Epub 2007 May 10.PMID: 17516410 [PubMed - indexed for MEDLINE]Related articles

    31.

    Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.

    Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G.

    Ann Intern Med. 2007 Apr 17;146(8):564-73.PMID: 17438315 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    High prevalence of subtherapeutic plasma concentrations of efavirenz in children.

    Ren Y, Nuttall JJ, Egbers C, Eley BS, Meyers TM, Smith PJ, Maartens G, McIlleron HM.

    J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):133-6.PMID: 17417100 [PubMed - indexed for MEDLINE]Related articles

    33.

    Response to "CD4 cell count natural history and informative censoring in sub-Saharan Africa".

    Holmes CB, Wood R, Maartens G, Freedberg KA, Losina E.

    J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):491. No abstract available. PMID: 17353721 [PubMed - indexed for MEDLINE]Related articles

    34.

    Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection.

    Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, Morroni C, Mouton P, Diwakar L, Connell TG, Maartens G, Wilkinson RJ.

    Am J Respir Crit Care Med. 2007 Mar 1;175(5):514-20. Epub 2006 Dec 7.PMID: 17158278 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study.

    Nachega JB, Knowlton AR, Deluca A, Schoeman JH, Watkinson L, Efron A, Chaisson RE, Maartens G.

    J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S127-33.PMID: 17133196 [PubMed - indexed for MEDLINE]Related articles

    36.

    Quantitative and functional differences between peripheral blood myeloid dendritic cells from patients with pleural and parenchymal lung tuberculosis.

    Mendelson M, Hanekom WA, Ntutela S, Vogt M, Steyn L, Maartens G, Kaplan G.

    Clin Vaccine Immunol. 2006 Dec;13(12):1299-306. Epub 2006 Sep 27.PMID: 17005928 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.

    Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, Chaisson RE, Maartens G.

    J Acquir Immune Defic Syndr. 2006 Sep;43(1):78-84.PMID: 16878045 [PubMed - indexed for MEDLINE]Related articles

    38.

    Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole.

    Schaars CF, Meintjes GA, Morroni C, Post FA, Maartens G.

    BMC Infect Dis. 2006 Jul 18;6:118.PMID: 16846523 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment.

    Holmes CB, Wood R, Badri M, Zilber S, Wang B, Maartens G, Zheng H, Lu Z, Freedberg KA, Losina E.

    J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):464-9.PMID: 16810113 [PubMed - indexed for MEDLINE]Related articles

    40.

    When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

    Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R.

    Antivir Ther. 2006;11(1):63-72.PMID: 16518961 [PubMed - indexed for MEDLINE]Related articles

    41.

    Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults.

    Wilson D, Nachega J, Morroni C, Chaisson R, Maartens G.

    Int J Tuberc Lung Dis. 2006 Jan;10(1):31-8.PMID: 16466034 [PubMed - indexed for MEDLINE]Related articles

    42.

    Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry.

    Mayosi BM, Wiysonge CS, Ntsekhe M, Volmink JA, Gumedze F, Maartens G, Aje A, Thomas BM, Thomas KM, Awotedu AA, Thembela B, Mntla P, Maritz F, Blackett KN, Nkouonlack DC, Burch VC, Rebe K, Parish A, Sliwa K, Vezi BZ, Alam N, Brown BG, Gould T, Visser T, Shey MS, Magula NP, Commerford PJ.

    BMC Infect Dis. 2006 Jan 6;6:2.PMID: 16396690 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Cost-effectiveness of highly active antiretroviral therapy in South Africa.

    Badri M, Maartens G, Mandalia S, Bekker LG, Penrod JR, Platt RW, Wood R, Beck EJ.

    PLoS Med. 2006 Jan;3(1):e4. Epub 2005 Dec 6.PMID: 16318413 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Diagnostic yield of peripheral lymph node needle-core biopsies in HIV-infected adults with suspected smear-negative tuberculosis.

    Wilson D, Nachega JB, Chaisson RE, Maartens G.

    Int J Tuberc Lung Dis. 2005 Feb;9(2):220-2.PMID: 15732745 [PubMed - indexed for MEDLINE]Related articles

    45.

    Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.

    Sanne I, Mommeja-Marin H, Hinkle J, Bartlett JA, Lederman MM, Maartens G, Wakeford C, Shaw A, Quinn J, Gish RG, Rousseau F.

    J Infect Dis. 2005 Mar 15;191(6):825-9. Epub 2005 Feb 10.PMID: 15717255 [PubMed - indexed for MEDLINE]Related articles

    46.

    Occupational post-exposure HIV prophylaxis.

    Maartens G.

    S Afr Med J. 2004 Aug;94(8):626-7. Review. No abstract available. PMID: 15352582 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Guideline for the management of upper respiratory tract infections.

    Brink AJ, Cotton MF, Feldman C, Geffen L, Hendson W, Hockman MH, Maartens G, Madhi SA, Mutua-Mpungu M, Swingler GH; Working Group of the Infectious Diseases Society of South Africa.

    S Afr Med J. 2004 Jun;94(6 Pt 2):475-83.PMID: 15244257 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Screening for tuberculosis in adults with advanced HIV infection prior to preventive therapy.

    Mohammed A, Ehrlich R, Wood R, Cilliers F, Maartens G.

    Int J Tuberc Lung Dis. 2004 Jun;8(6):792-5.PMID: 15182152 [PubMed - indexed for MEDLINE]Related articles

    49.

    The short-term effects of anti-tuberculosis therapy on plasma pyridoxine levels in patients with pulmonary tuberculosis.

    Visser ME, Texeira-Swiegelaar C, Maartens G.

    Int J Tuberc Lung Dis. 2004 Feb;8(2):260-2.PMID: 15139457 [PubMed - indexed for MEDLINE]Related articles

    50.

    Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa.

    Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, Reuter H, Ntwana N, Goemaere E.

    AIDS. 2004 Apr 9;18(6):887-95.PMID: 15060436 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...